Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

    Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen
    e2023026
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.026
    4814
    HTML: 329
    PDF: 1319
  • ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE

    Lijie Ma, Ling Chen
    e2026034
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.034
    201
    PDF: 299
    Suppl. Files: 53
    HTML: 62
  • DYNAMIC MULTIPLEX CYTOKINE PROFILING TO IDENTIFY RISK FACTORS FOR LUNG CONSOLIDATION AND NECROTIZING TRANSFORMATION IN CHILDREN WITH MYCOPLASMA PNEUMONIAE PNEUMONIA

    Hailiang Yan, Chuyi Zhang
    e2026008
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.008
    786
    PDF: 616
    Suppl. Files: 175
    Html: 121
  • AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging

    Dr.Sophia Delicou, Dr.Ioannis Ilias, Dr.Athanasia Kapota, Dr.Elena Papatheodorou, Dr.Maria Moraki, Dr.Aikaterini Xydaki, Dr.Alexandra Mika, Dr.Panagiota Giannou, Dr.Irene Kouroukli, Dr.Theodoros Aforozis, Dr.Myrto Palkopoulou, Dr.Christos Savvidis, Dr.Iliana Mani, Prof.Constantina Aggeli, Prof. John Koskinas
    e2026039
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.039
    439
    PDF: 430
    Suppl. Files: 60
    HTML: 32
  • EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis

    ChunYan Zong, FeiFeng Wu, FenFen Chen, JiaoJiao Yang, Hong Zhou, BaoFeng Zhu
    e2026045
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.045
    300
    PDF: 312
    HTML: 37
  • DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura

    Yi Liu, Fan Lu, Binbin Ji, Wei Song, Hui Shen, Yingjie Xu, bining Yang
    e2026019
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.019
    770
    PDF: 669
    HTML: 94
  • END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life

    Dr. Sophia Delicou, Dr Katerina Xydaki, Dr Maria Moraki, Dr Theodoros Aforozis
    e2026015
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.015
    1116
    PDF: 786
    Html: 168
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1119
    PDF: 882
    HTML: 255
  • APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

    Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso
    e2012015
    2012-03-10
    https://doi.org/10.4084/mjhid.2012.015
    2617
    PDF: 993
    HTML: 15126
  • EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-

    Hanchen Liu, Weizhen Wang, Yuqing Dong
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.020
    697
    PDF: 537
    HTML: 112
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1357
    PDF: 1574
    Suppl. Files: 161
    HTML: 86
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1496
    PDF: 549
    HTML: 201
  • GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE

    Lang Peng, Lixin Zou, Xiaoliu Liu
    e2025012
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.012
    1040
    PDF: 1040
    Suppl. Files: 652
    HTML: 167
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3835
    PDF: 1081
    HTML: 2103
  • Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples

    Antonio Amato, Piero C Giordano
    e2009007
    2009-08-07
    1241
    PDF: 493
    HTML: 1169
    Amato1: 172
    Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 260
    jdoe, : 254
    Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 163
  • MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY

    Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno
    e2017021
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.021
    3485
    PDF: 1320
    HTML: 1939
    Fig.1: 223
    Fig. 2: 221
  • DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.

    Matteo Della Porta, Cristina Picone
    e2017017
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.017
    4874
    PDF: 1857
    HTML: 2171
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1610
    PDF: 1059
    HTML: 263
  • The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE

    Jialian Li
    e2020029
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.029
    1874
    PDF: 986
    HTML: 282
  • CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA

    Neryal Tahta, Tuba Hilkay Karapınar, Sultan Okur Acar, Ayşe Erol, İlker Devrim, Yesim Oymak, Salih Gozmen, Canan Raziye Vergin
    e2026004
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.004
    958
    PDF: 713
    HTML: 120
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2497
    PDF: 894
    HTML: 2469
  • COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis

    Vahibe Aydın Sarıkaya, gülşah Tunçer, sevim Özdemir, Rüştü Türkay, Burak Sarıkaya, Saime Gül Barut, Esen Gül Uzuner, Filiz Pehlivanoğlu
    e2025078
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.078
    583
    PDF: 332
    Html: 29
  • IMMUNOLOGY OF TUBERCULOSIS

    Federica Bozzano, Francesco Marras, Andrea De Maria
    e2014027
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.027
    5464
    PDF: 2041
    HTML: 7344
    Untitled: 204
  • SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

    Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
    e2024006
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.006
    1229
    PDF: 1315
    HTML: 212
  • THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

    George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe
    e2020011
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.011
    2468
    PDF: 1613
    HTML: 664
  • Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

    Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini
    e2024047
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.047
    1188
    PDF: 1010
    HTML: 95
  • DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis

    Vishal Vishnu Tewari
    e2021019
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.019
    1740
    PDF: 604
    HTML: 459
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2211
    PDF: 762
    HTML: 1638
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    277
    PDF: 292
    Suppl. Files: 48
    HTML: 42
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4276
    PDF: 1233
    HTML: 1218
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    947
    PDF: 668
    HTML: 166
  • ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

    chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi
    e2019066
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.066
    1441
    PDF: 904
    HTML: 1881
  • SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

    Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso
    e2011052
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.052
    3716
    PDF: 913
    HTML: 6729
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3860
    PDF: 1699
    HTML: 11659
    Figures Haase: 220
  • REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

    Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah
    e2021017
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.017
    1683
    PDF: 564
    HTML: 346
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2867
    PDF: 1034
    HTML: 5531
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3783
    PDF: 1500
    HTML: 190
  • THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA

    Umberto Ricardi, Andrea Riccardo Filippi, Cristina Piva, Pierfrancesco Franco
    e2014035
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.035
    2274
    PDF: 964
    HTML: 6798
    Figure 1: 188
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia

    Gabriele Magliano, Andrea Bacigalupo
    e2020081
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.081
    1680
    PDF: 527
    HTML: 170
  • DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE

    Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende
    e2012036
    2012-05-09
    https://doi.org/10.4084/mjhid.2012.036
    3673
    PDF: 1134
    HTML: 23358
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9215
    PDF: 6139
    HTML: 87998
    Fig.1b: 197
    Fig.1c: 205
    Fig.2a: 191
    Fig.2b: 190
    Fig.4: 207
    Fig.2c: 194
    Fig.3: 195
    Tab.1: 246
    Tab.2: 220
    Tab.3: 205
    Tab.4: 240
    Fig1a: 203
  • Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

    Daniele Derudas
    e2025025
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.025
    1591
    PDF: 1404
    HTML: 139
1 - 42 of 42 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.